Multiple Sclerosis Clinical Trial
Effect of Ocrelizumab on Choroid Plexus Changes in Patients With PPMS
The goal of this non-interventional, observational study is to learn if cortical plexus enhancement in patients with primary progressive multiple sclerosis occurs in response to the autoimmune inflammatory process.
To study the effect of ocrelizumab on choroid plexus changes in patients with primary-progressive multiple sclerosis participating in the ORATORIO: a post-hoc analysis of a double-blind, randomized, phase 3, placebo-controlled study
Patient participating in the ORATORIO study
MRI scans available at baseline
Presence of T2-weighted image (WI) (FLAIR, T2/PD), and 3D T1-WI at baseline
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Buffalo New York, 14203, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.